Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: A systematic review and meta-analysis

Drug and Alcohol Dependence

Volumn 126, Issue 3, 2012, Pages 286-295

  Zhuang, Xun ^a,b   Wang, Yafei ^a   Chow, Eric P F ^b   Liang, Yanxian ^a   Wilson, David P ^b   Zhang, Lei ^b  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

China; HCV; HIV; Meta analysis; Methadone maintenance treatment; Odds ratio

Indexed keywords

ANTIRETROVIRUS AGENT; METHADONE;

ARTICLE; CHINA; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG USE; GENDER; GEOGRAPHY; GROUPS BY AGE; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH PROGRAM; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; META ANALYSIS; PRIORITY JOURNAL; PSYCHOTHERAPY; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; CHINA; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; RISK FACTORS; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84869207144     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.05.028     Document Type: Article

References (106)

1. Alter M.J. Prevention of spread of hepatitis C. Hepatology 2002, 36:s93-s98.
2. Bai Y., Lai W.S., Wei L. Prevalence of HIV, HCV and syphilis infection at methadone maintenance treatment clinic in Liuzhou City. J. Prev. Med. Inf. 2009, 25:910-912.
3. Bao Y., Liu Z. Systematic review of HIV and HCV infection among drug users in China. Int. J. STD AIDS 2009, 20:399.
4. Bennett G.A., Velleman R.D., Barter G., Bradbury C. Gender differences in sharing injecting equipment by drug users in England. AIDS Care 2000, 12:77-87.
5. Boyle M.H. Guidelines for evaluating prevalence studies. Evid. Based Ment. Health 1998, 1:37-39.
6. Cai C.P., Zhou Z.M., Chen L.X. Investigation of AIDS, hepatitis B and C among methadone-treated drug addicts women of childbearing age. Dis. Surveill. 2008, 23:126-127.
7. Celentano D.D., Jittiwutikorn J., Hodge M.J., Beyrer C., Nelson K.E. Epidemiology of HIV-1 infection in opiate users in northern Thailand. J. Acquir. Immune Defic. Syndr. 1998, 17:73.
8. Chen L.F. Survey of infectious status of HIV, HBV, syphilis and HCV on 459 drug users. Pract. Prev. Med. 2009, 16:1641-1642.
9. Chen L.K., Li W.J., Mai R.J., Liu C.J., Fan Z.F., Chen Z.F., Feng J.P. Assessment of results of exchange of syringe among drug users in preventing the transmission of HIV/AIDS. China Trop. Med. 2007, 7:2138-2142.
10. Chen W., Ling L., Qun H.E., Chen A., Chen J., Xia Y.H. Perfomance evaluation and policy recommendations on community methadone maintenance treatment in Guangdong Province. Chin. J. Health Policy 2010, 3:6.
11. Cheng X.L., Wang F.H., Xiao Y.K. Analysis on the data of HIV Sentinel Surveillance in 2002-2006 in Anhui Province. Anhui J. Prev. Med. 2009, 15:81-84.
12. Choi S.Y., Cheung Y.W., Chen K. Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China. Soc. Sci. Med. 2006, 62:1672-1684.
13. Crofts N., Aitken C.K. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med. J. Aust. 1997, 167:17-20.
14. Davies A.G., Dominy N.J., Peters A.D., Richardson A.M. Gender differences in HIV risk behaviour of injecting drug users in Edinburgh. AIDS Care 1996, 8:517-527.
15. Deng L.P., Gui X.E., Wang X. A survey of HIV, HBV, HCV, HGV and TTV infections among drug abusers in Hubei Province. Hubei J. Prev. Med. 2003, 14:1-2.
16. Division of Policy Research and Information NCAIDS, CDC, C., 2010. Gender Analysis of Data on HIV Epidemic and Response in Six Provinces (Guangdong, Guangxi, Yunnan, Henan, Hubei and Chongqing), China.
17. Doherty M.C., Garfein R.S., Monterroso E., Brown D., Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS 2000, 14:717-726.
18. Dole V.P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. JAMA 1965, 193:646.
19. Dong G., Jia H. HIV, HCV and syphilis infection among drug users in Luzhou City. J. Prev. Med. Infect. 2009, 25:55-57.
20. Du W.J., Xiang Y.T., Wang Z.M., Chi Y., Zheng Y., Luo X.N., Cai Z.J., Ungvari G.S., Gerevich J. Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug Alcohol Depend. 2008, 94:158-164.
21. Evans J.L., Hahn J.A., Page-Shafer K., Lum P.J., Stein E.S., Davidson P.J., Moss A.R. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J. Urban Health 2003, 80:137-146.
22. Fang Y.X., Wang Y.B., Shi J., Liu Z.M., Lu L. Recent trends in drug abuse in China. Acta Pharmacol. Sin. 2006, 27:140-144.
23. Freeman R.C., Rodriguez G.M., French J.F. A comparison of male and female intravenous drug users' risk behaviors for HIV infection. Am. J. Drug Alcohol Abuse 1994, 20:129-157.
24. Fu F.Y., Qian Y.P. Detection results of HIV, HCV and syphilis and behavior characteristics among 349 drug users in Hangzhou City. J. Radioimmunol. 2009, 22:639-640.
25. Garten R.J., Lai S., Zhang J., Liu W., Chen J., Vlahov D., Yu X.F. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int. J. Epidemiol. 2004, 33:182-188.
26. Gaskin S., Brazil C., Pickering D. The sharing of injecting paraphernalia by intravenous drug users (IDUs) within a Worcestershire cohort, with specific reference to water and filters. Int. J. Drug Policy 2000, 11:423-435.
27. Guo W., Qu S.Q., Ding Z.W., Yan R.X., Li D.M., Wang L. Situations and trends of HIV and syphilis infections among drug users in China, 1995-2009. Zhonghua Liu Xing Bing Xue Za Zhi 2010, 31:666-669.
28. Hao X.Q. Survey on infection of HIV and HCV among 277 cases of methadone maintenance treatment. Qinghai Med. J. 2009, 75-76.
29. Hu M., Wang X., Yuan Y., Liao K.K., Zhao X.H., Li M., Zhang G.G., Kang L., Ding Y., Li B., Li J. Effect of family intervention on maintenance of methadone maintain treatment. Pract. J. Clin. Med. 2009, 6:2.
30. Jia Y., Lu F., Zeng G., Sun X., Xiao Y., Lu L., Liu W., Ni M., Qu S., Li C., Liu J., Wu P., Vermund S.H. Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: community-based surveys along major drug trafficking routes. Harm Reduct. J. 2008, 5:29.
31. Kerr T., Marsh D., Li K., Montaner J., Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend. 2005, 80:329-335.
32. Kerr T., Stoltz J.A., Strathdee S., Li K., Hogg R.S., Montaner J.S., Wood E. The impact of sex partners' HIV status on HIV seroconversion in a prospective cohort of injection drug users. J. Acquir. Immune Defic. Syndr. 2006, 41:119-123.
33. Khan K.S., Kunz R., Kleijnen J., Antes G. Five steps to conducting a systematic review. J. Rev. Soc. Med. 2003, 96:118-121.
34. Kral A.H., Bluthenthal R.N., Lorvick J., Gee L., Bacchetti P., Edlin B.R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001, 357:1397-1401.
35. Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann. N.Y. Acad. Sci. 2004, 1025:446-457.
36. Lai S., Chen J., Celentano D., Page J.B., Lai H., Yang J., Liu W., McCoy C.B., Yu X.F. Adoption of injection practices in heroin users in Guangxi Province, China. J. Psychoactive Drugs 2000, 32:285-292.
37. Li J., Zhou J., Huang B., Chen Z.Q., Zheng X.M. Reasons of heroin use during methadone maintenance treatment and effect of patient intervention on IT. Chin. J. Drug Depend. 2010, 19.
38. Li P.K., Luo J., Zhang C.M., Yang G.G., Li J.H. Effects of social function rehabilitation intervention on social support and happiness in patients receiving methadone maintenance treatment. Chin. Ment. Health J. 2010, 24.
39. Li Q., Chen G.C. Influence of nursing intervene in detoxicant effect in heroin dependence. Chin. J. Misdiagn. 2007, 7:2.
40. Li W.J., Fan Z.F., Lin P. A survey of HIV and HCV infections and related knowledge and behavioramong drug abusers in Yangjiang City, South China. Prev. Med. 2004, 30:17-19.
41. Li X.L., Tan H.Z., Sun Z.Q., Zhang H., Chen M.S., Ou Q.Y. Study on the time of retention and related influencing factors of patients receiving methadone maintenance treatment in Hunan province. Chin. J. Epidemiol. 2009, 30:672-675.
42. Li Y.C., Jia W., Shen D.H., Wang F., Zhang R. Analysis of influencing factors of HCV infection in drug users from methadone maintenance therapy clinic in Xi'an. Chin. J. Drug Abuse Prev. Treat. 2009, 15:207-209.
43. Liu H.B., Zhe X.L. Study on HCV co-infection in Yulin drug users. J. Med. Pest Control 2010, 731-732.
44. Liu J.B., Di L.X.T., Li F., Zhang F., Mo L.R., Jiao L.D., Ai N.W.E., Wang J.M. The effective evaluation of the methadone maintenance treatment of heroin addicts. Chin. J. Drug Abuse Prev. Treat. 2007, 13:4.
45. Lu L., Jia M., Ma Y., Yang L., Chen Z., Ho D.D., Jiang Y., Zhang L. The changing face of HIV in China. Nature 2008, 455:609-611.
46. Mao N.L., Lu M.M., Qin Q.R., Zhu H.B., Zhang Z., Ding Y.X., Ye D.X. HIV, syphilis infections and their behavior characteristics analysis among drug users in Maanshan City, Anhui Province. Chin. J. Dis. Control Prev. 2010, 729-732.
47. Ministry of Health People's Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization, 2011. 2011 Estimates for the HIV/AIDS Epidemic in China, Beijing.
48. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097.
49. Murrill C.S., Weeks H., Castrucci B.C., Weinstock H.S., Bell B.P., Spruill C., Gwinn M. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am. J. Public Health 2002, 92:385.
50. Nelson K.E., Vlahov D., Solomon L., Cohn S., Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch. Intern. Med. 1995, 155:1305-1311.
51. Nelson P.K., Mathers B.M., Cowie B., Hagan H., Des Jarlais D., Horyniak D., Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011, 378:571-583.
52. Pang L., Hao Y., Mi G., Wang C., Luo W., Rou K., Li J., Wu Z. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007, 21:S103.
53. Patrick D.M., Strathdee S.A., Archibald C.P., Ofner M., Craib K.J., Cornelisse P.G., Schechter M.T., Rekart M.L., O'Shaughnessy M.V. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int. J. STD AIDS 1997, 8:437-445.
54. Peng Z.Q. AIDS epidemic status in Shenzhen, 1992-2003. S. China J. Prev. Med. 2004, 30:20.
55. Qi R.L. The effects of comprehensive psychological intervention in the treatment of heroin addicts. Int. J. Nurs. 2008, 27:3.
56. Qian H.Z., Hao C., Ruan Y., Cassell H.M., Chen K., Qin G., Yin L., Schumacher J.E., Liang S., Shao Y. Impact of methadone on drug use and risky sex in China. J. Subst. Abuse Treat. 2008, 34:391-397.
57. Qian H.Z., Schumacher J.E., Chen H.T., Ruan Y.H. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduct. J. 2006, 3:4.
58. Ruan Y., Chen K., Hong K., He Y., Liu S., Zhou F., Qin G., Chen J., Xing H., Shao Y. Community-based survey of HIV transmission modes among intravenous drug users in Sichuan, China. Sex Transm. Dis. 2004, 31:623-627.
59. Ruan Y., Qin G., Yin L., Chen K., Qian H.Z., Hao C., Liang S., Zhu J., Xing H., Hong K., Shao Y. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study. AIDS 2007, 21(Suppl. 8):S39-S46.
60. Shi P.L.L. Survey and analysis on the HCV infection among drug users. Jiangsu J. Prev. Med. 2009, 20:10-12.
61. Shi P., Xu J., Liu C., Li X.H., Hu J., Zhang W.H., Zhou W. Analysis on the status of accepting AIDS preventive intervention among drug users. Chin. J. Soc. Med. 2010, 27.
62. Solomon L., Astemborski J., Warren D., Munoz A., Cohn S., Vlahov D., Nelson K.E. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am. J. Epidemiol. 1993, 137:892-898.
63. Song H.B. Epidemiological survey on the HCV infection among drug users at methadone maintenance treatment in Nantong city. Med. J. Chin. People Health 2010, 22:22-23.
64. Strathdee S.A., Galai N., Safaiean M., Celentano D.D., Vlahov D., Johnson L., Nelson K.E. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch. Intern. Med. 2001, 161:1281-1288.
65. Su M.F. HIV, HCV and TB infection among drug users receiving methadone treatment in Yuhuan country, Zhejiang province. Dis. Surveill. 2010, 302-304.
66. Sun Y.D., Meng Z.D., Wang S.Y., Chen X.R., Sun D.G., Chen Z., Liu C.B., Zhuang H. Epidemiologic investigation on an outbreak of hepatitis C. Chin. Med. J. (Engl.) 1991, 104:975-979.
67. Sy T., Jamal M.M. Epidemiology of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 2006, 3:41-46.
68. Tan X.L., Luo B.S., Zhu L.X. Investigation on AIDS related KAP among drug users in Chongqing. Mod. Prev. Med. 2007, 34:1152-1153.
69. The Ministry of Public Security of the People's Republic of China, 2010. 1.33 Million Registered Drug Users Nationally in China, Beijing, vol. 2012. http://www.mps.gov.cn/n16/n1252/n1897/n2872/2327636.html.
70. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., Monterroso E.R., Garfein R.S. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 2002, 155:645-653.
71. Van Den Hoek J., Van Haastrecht H., Coutinho R. Homosexual prostitution among male drug users and its risk for HIV infection. Genitourin. Med. 1991, 67:303-306.
72. Villano S.A., Vlahov D., Nelson K.E., Lyles C.M., Cohn S., Thomas D.L. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J. Clin. Microbiol. 1997, 35:3274-3277.
73. Wang D.Y., Chen Y.M., Huang Q.L., Zhou M., Chen H.M., Pan L. Infection and risk factors of HIV and HCV among drug users in Zigong City. S. China J. Prev. Med. 2009, 38-40.
74. Wang H.Q., Yu E.Z. Analysis of the detoxification difficulty among 155 voluntary detoxification. J. Qiqihar Med. Coll. 2000, 21:652-653.
75. Wang J., Yang X.J. Prevalence of HIV, HCV infection and syphilis among drug users at methadone maintenance clinics in Anshun. J. Occup. Health Damage 2010, 25:145-148.
76. Wang N.C., Qiao X.C., Zhang L.F. Seroepidemiology of HCV infection among different populations in Shanxi. China Public Health 2001, 17:703.
77. Wang S., Ding H., Zhang H. Hepatitis C virus infection among the plasmapheresis donors. Zhonghua Liu Xing Bing Xue Za Zhi 1994, 15:71-73.
78. Wang X., Li D.Q., Huang M.Z., Guan L.H.L. Prevalence of hepatitis C virus infection among drug users and the related factors. Chin. J. Pract. Med. 2005, 4:20-21.
79. Ward J., Hall W., Mattick R.P. Role of maintenance treatment in opioid dependence. Lancet 1999, 353:221-226.
80. Weeks M.R., Grier M., Romero-Daza N., Puglisi-Vasquez M.J., Singer M. Streets, drugs, and the economy of sex in the age of AIDS. Women Health 1998, 27:205-209.
81. Wei X.L., Li H.X., Ma C.F., Liu J.F. Effective evaluation of methadone maintenance treatment for heroin dependent patients in Xi'an city. Chin. J. Drug Depend. 2008, 17:5.
82. Wu G.H., Chen H., Meng X., Zhou C. Epidemiological survey on the HCV and HIV infection among drug users in Chongqing City. Mod. Prev. Med. 2010, 37:134-136.
83. Wu Z. Landmark Government Methadone Maintenance Program in Mainland China. 15th International AIDS Conference 2004.
84. Wu Z. Methadone maintenance program in mainland China: from pilot to scale-up. International Conference on the Reduction of Drug Related Harm 2005.
85. Wu Z., Luo W., Sullivan S.G., Rou K., Lin P., Liu W., Ming Z. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS 2007, 21(Suppl. 8):S115-S122.
86. Xia L., Zhang Q.S., Deng X.L., Li C.X., Shen J., Liu T., Cai C.L., Liu W.H., Chen Y.Q., Yang M. Prevalence of HIV, HCV and Syphilis among heroin addicts at methadone maintenance treatment clinic in Shenzhen city. Chin. J. Drug Abuse Prev. Treat. 2010, 16:63-65.
87. Xia X., Luo J., Dong J., You H., Qian Y.H., Qian X.C., Yu R.B. Epidemiological survey on the HCV infection among drug users in some areas of Jiangsu. Mod. Prev. Med. 2007, 34:4616-4618.
88. Xiang L., Jiang J.Y., He J., Li H., Chen H.M., He N. Analysis of HCV infection among drug users in methadone clinics in Wuhua District of Kunming. Fourth National Symposium on Immunodiagnostic and Vaccine 2009.
89. Xie L.Z., Chen X., Hu W.H.Z., Liu B., Xing L., Yang Z.H., Liang Z.N., Zhang S., Yin L., Wang L., Chen J., Qin K.L., Yuan G.M., Shao Y.H.Y.M. Investigation into the relationship between the high risk behavior of drug using population and HCV infection. China Trop. Med. 2006, 6:1140-1142.
90. Xu C., Pang L., Wu Z.Y. Human immunodeficiency virus and hepatitis C virus infections among drug users in China. Chin. J. Dis. Control 2009, 13:4.
91. Xu S.M., Qian T.X., Peng C.L., Yang M.F., Lu R.R. Surveillance on HIV and syphilis infection in Chongqing City, 2004. Mod. Prev. Med. 2006, 33:833-834.
92. Yang J., Ding J.J., Li Y.Y. Co-infection with HCV and HGV among 107 injection drug users. Chin. J. Prev. Med. 2000, 34:85.
93. Yang L.S. Reasons dropout from methadone maintenance treatment of 93 cases. J. Dali Univ. 2008, 7:3.
94. Yang Y.C., Duan S., Xiang L.F., Ye R.H., Gao J., Yang S.S., Yang Y.B. Adherence and related determinants methadone maintenance treatment among heroin addicts in Dehong prefecture, Yunnan province. Chin. J. Epidemiol. 2011, 32:125-129.
95. Yao W., Jiang Z.H., Jia S.G., Yang H., Liao K.K. Prevalence of HIV, HCV and syphilis infection at methadone maintenance treatment clinic in Mianyang City. J. Prev. Med. Inf. 2008, 24:498-500.
96. Yin L., Zhang Y., Qian H.Z., Rui B., Zhang L., Zhu J., Guan Y., Wang Y., Li Q., Ruan Y., Shao Y. Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine 2008, 26:762-768.
97. Yin W., Hao Y., Sun X., Gong X., Li F., Li J., Rou K., Sullivan S.G., Wang C., Cao X., Luo W., Wu Z. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int. J. Epidemiol. 2010, 39(Suppl. 2):ii29-ii37.
98. Zhang J.F., Li J., Zhang F.Q., Zhai X.M., Qiao Y., Luo C. Investigation on HCV infection among drug users in methadone maintenance treatment. Chin. J. Drug Abuse Prev. Treat. 2010, 16:88-90.
99. Zhang W.D. Characteristics of drug users with co-infection AIDS and syphilis. China Pract. Med. 2009, 9.
100. Zhang Y., Zhang X., Hanko Aleong T., Fuller-Thomson E. Impact of HIV/AIDS on social relationships in Rural China. Open AIDS J. 2011, 5:67-73.
101. Zhao J.X., Chen L., Xu J., Lu J.B., Cai Y., Chen L.Y. Investigation of HIV, HCV and syphilis infection and associated behaviors among drug addicts in Yuxi, Yunnan province. Dis. Surveill. 2008, 23:558-559.
102. Zhao Y.N., Zhang X.D., Li S.Y., Chen J., Guo X.H., Xu K., Jiang J.X. Behaviors and related factors of female drug users. Chin. J. Behav. Med. Sci. 2000, 9:55.
103. Zhou X., Zhang X., Zhou X.M. HIV, HCV examination data analysis among drug users treated with oral methadone maintenance in Panzhihua City from 2005 to 2007. Prev. Med. Trib. 2009, 15:745-746.
104. Zhu W.J., Huang E., Chen X.B., Chen J.H., Wu Y.P., Yan Q.L., Zhang C.J., Zhang L.Y. An analysis of the quality of life and related faceors in herion addicts enforcing detoxification. Chin. J. Behav. Med. Sci. 2005, 14:327-329.
105. Zhu X., Kang D., Liu X., Liao M., Fu J. Analysis of behavioral changes among clandestine prostitutes in Jiaozhou city. Chin. J. AIDS STD 2008, 14:28-30.
106. Zhu X.H., Wei X.L., Gao L., Peng J.J. Monitoring and analysis of clinical blood in 613 MMT clients. Chin. J. Drug Abuse Prev. Treat. 2010, 16:340-342.